BX-795 inhibits HSV-1 and HSV-2 replication by blocking the JNK/p38 pathways without interfering with PDK1 activity in host cells

Airong Su(Faculty of Public Health), Zhiwei Wu(Nanjing University)
Acta Pharmacologica Sinica
January 23, 2017
Cited by 47


Related Papers